Literature DB >> 33534855

Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques.

Joseph R Albe1, Henry Ma1,2, Theron H Gilliland1, Cynthia M McMillen1,2, Christina L Gardner1, Devin A Boyles1, Emily L Cottle1, Matthew D Dunn1, Jeneveve D Lundy1, Katherine J O'Malley1, Noah Salama2, Aaron W Walters1,2, Ivona Pandrea3, Tobias Teichert4,5, William B Klimstra1,6, Douglas S Reed1,6, Amy L Hartman1,2.   

Abstract

Aerosol exposure to eastern equine encephalitis virus (EEEV) can trigger a lethal viral encephalitis in cynomolgus macaques which resembles severe human disease. Biomarkers indicative of central nervous system (CNS) infection by the virus and lethal outcome of disease would be useful in evaluating potential medical countermeasures, especially for therapeutic compounds. To meet requirements of the Animal Rule, a better understanding of the pathophysiology of EEEV-mediated disease in cynomolgus macaques is needed. In this study, macaques given a lethal dose of clone-derived EEEV strain V105 developed a fever between 2-3 days post infection (dpi) and succumbed to the disease by 6 dpi. At the peak of the febrile phase, there was a significant increase in the delta electroencephalography (EEG) power band associated with deep sleep as well as a sharp rise in intracranial pressure (ICP). Viremia peaked early after infection and was largely absent by the onset of fever. Granulocytosis and elevated plasma levels of IP-10 were found early after infection. At necropsy, there was a one hundred- to one thousand-fold increase in expression of traumatic brain injury genes (LIF, MMP-9) as well as inflammatory cytokines and chemokines (IFN-γ, IP-10, MCP-1, IL-8, IL-6) in the brain tissues. Phenotypic analysis of leukocytes entering the brain identified cells as primarily lymphoid (T, B, NK cells) with lower levels of infiltrating macrophages and activated microglia. Massive amounts of infectious virus were found in the brains of lethally-infected macaques. While no infectious virus was found in surviving macaques, quantitative PCR did find evidence of viral genomes in the brains of several survivors. These data are consistent with an overwhelming viral infection in the CNS coupled with a tremendous inflammatory response to the infection that may contribute to the disease outcome. Physiological monitoring of EEG and ICP represent novel methods for assessing efficacy of vaccines or therapeutics in the cynomolgus macaque model of EEEV encephalitis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33534855      PMCID: PMC7886169          DOI: 10.1371/journal.ppat.1009308

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  42 in total

1.  Eastern equine encephalomyelitis in Massachusetts; report of two cases, diagnosed serologically, with complete clinical recovery.

Authors:  H F DE WEBSTER
Journal:  N Engl J Med       Date:  1956-08-09       Impact factor: 91.245

2.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

3.  Saccadic spike potentials in gamma-band EEG: characterization, detection and suppression.

Authors:  Alon S Keren; Shlomit Yuval-Greenberg; Leon Y Deouell
Journal:  Neuroimage       Date:  2009-10-27       Impact factor: 6.556

4.  Clinical and neuroradiographic manifestations of eastern equine encephalitis.

Authors:  R L Deresiewicz; S J Thaler; L Hsu; A A Zamani
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

5.  Eastern Equine Encephalitis Virus - Another Emergent Arbovirus in the United States.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  N Engl J Med       Date:  2019-11-21       Impact factor: 91.245

Review 6.  Encephalitic alphaviruses.

Authors:  Michele A Zacks; Slobodan Paessler
Journal:  Vet Microbiol       Date:  2009-08-28       Impact factor: 3.293

7.  Beta- and gamma-range human lower limb corticomuscular coherence.

Authors:  Joseph T Gwin; Daniel P Ferris
Journal:  Front Hum Neurosci       Date:  2012-09-11       Impact factor: 3.169

8.  Complete coding sequences of eastern equine encephalitis virus and venezuelan equine encephalitis virus strains isolated from human cases.

Authors:  Guo-Yun Yu; Michael R Wiley; Jeffrey R Kugelman; Jason T Ladner; Brett F Beitzel; Lori T Eccleston; Elaine M Morazzani; Pamela J Glass; Gustavo F Palacios
Journal:  Genome Announc       Date:  2015-04-23

9.  Molecular epidemiology of eastern equine encephalitis virus, New York.

Authors:  David S Young; Laura D Kramer; Joseph G Maffei; Robert J Dusek; P Bryon Backenson; Christopher N Mores; Kristen A Bernard; Gregory D Ebel
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

Review 10.  Neurotropic virus infections as the cause of immediate and delayed neuropathology.

Authors:  Martin Ludlow; Jeroen Kortekaas; Christiane Herden; Bernd Hoffmann; Dennis Tappe; Corinna Trebst; Diane E Griffin; Hannah E Brindle; Tom Solomon; Alan S Brown; Debby van Riel; Katja C Wolthers; Dasja Pajkrt; Peter Wohlsein; Byron E E Martina; Wolfgang Baumgärtner; Georges M Verjans; Albert D M E Osterhaus
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

View more
  1 in total

1.  Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus.

Authors:  Henry Ma; Joseph R Albe; Theron Gilliland; Cynthia M McMillen; Christina L Gardner; Devin A Boyles; Emily L Cottle; Matthew D Dunn; Jeneveve D Lundy; Noah Salama; Katherine J O'Malley; Ivona Pandrea; Tobias Teichert; Stacey Barrick; William B Klimstra; Amy L Hartman; Douglas S Reed
Journal:  PLoS Pathog       Date:  2022-06-13       Impact factor: 7.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.